Rising prevalence of ovarian cancer and growing focus on early detection and treatment are expected to fuel market growth.
Rising prevalence of ovarian cancer and growing focus on early detection and treatment are expected to fuel market growth.
The global ovarian cancer diagnostics market size is expected to reach USD 2.3 billion by 2028, registering a CAGR of 6.7% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are rising prevalence of ovarian cancer and increasing awareness about the importance of early detection of ovarian cancer.
Ovarian cancer is the seventh leading cause of death and morbidity in women worldwide. It is a complicated type of cancer that often affects women over the age of 65. Various studies have established the age group of 50–79 years as the average for diagnosis. Women have a one-in-75 risk of developing ovarian cancer and a one-in-one-hundred chance of dying from it. The prevalence of the disease varies by age and race, with the latter being more prevalent in less developed countries. Ovarian cancer incidence rates in Europe increased significantly from 1982 to 2008, increasing from 4.9 to 6.1 per 100,000 females. In the U.S., ovarian cancer accounted for 81.8 percent of all cancer cases in 2012.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4093
Ovarian cancer is most common in women between the ages of 50 and 79. It is becoming more prevalent as the world’s geriatric population grows and there is a greater emphasis on early detection and treatment, which is expected to accelerate ovarian cancer diagnostic market development. Increasing government investment in raising awareness about early cancer detection as well as increasing health-care spending would also propel business growth.
Obesity appears to play a significant role in the development of ovarian cancer. Other lifestyle choices that can raise the risk include smoking, drinking, and not having children. Since ovarian cancer is not easily detectable, women who are at risk of developing the disease must undergo routine testing to identify the disease early, allowing the market to expand.
Lack of knowledge about the exact causative factors and a late diagnosis of the disease are two major factors limiting development. In order to identify key genes or biochemical pathways that could be targeted for diagnosis and treatment, a better understanding of the underlying molecular processes is critical.
Some Key Highlights in the Report:
- Epithelial tumours segment is expected to account for largest market share over the coming years.
- Imaging techniques segment is expected to register a robust CAGR among the diagnosis type segments during the forecast period.
- Hospital laboratories segment accounted for largest revenue share among end user segments in the global market in 2020.
- Ongoing research and development in the ovarian cancer diagnostics market in North America will contribute to the relatively higher market share held by the region.
- Due to factors, such as improved healthcare infrastructure, increased disposable income, and increased awareness, Asia Pacific ovarian cancer diagnostics market is expected to expand at fastest pace during the forecast period.
- Some of the prominent players in the ovarian cancer diagnostics market include F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Johnson & Johnson Services, Inc.; AstraZeneca plc; Siemens Healthcare GmbH; Quest Diagnostics Incorporated.; Thermo Fisher Scientific; Bio-Rad Technologies Inc.; and Abbott.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/ovarian-cancer-diagnostics-market
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the global ovarian cancer diagnostics market on the basis of cancer type, diagnosis type, end user, and region:
Cancer Type Outlook (Revenue, USD Billion; 2018 – 2028)
- Epithelial Tumour
- Germ Cell Tumour
- Stromal Cell Tumour
- Others
Diagnosis Type Outlook (Revenue, USD Billion; 2018 – 2028)
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
End User Outlook (Revenue, USD Billion; 2018 – 2028)
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/4093
Regional Outlook (Revenue, USD Billion; 2018 – 2028)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4093
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Dental Imaging Market , By Product (Extraoral Imaging System, Intraoral Imaging System), By End-use, By Application, and By Region, Forecast To 2028
Nurse Call System Market , By Type (Integrated Communication Systems, Button-based Systems, Intercom Systems, Mobile Systems), By Technology, By Application, By End-use, and By Region Forecast To 2028
Valley Fever Market , By Product Type (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others), By End-Use (People, Cattle, Sheep And Goats, Camel, Others), and By Region Forecast to 2028
Air Sampler Market , By Product Type (Portable Air Samplers, Desktop Air Samplers, Others), By Application (Chemical Industry, Pharmaceutical Industry, Food and Beverages Industry, Environmental Monitoring, Others), and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-ovarian-cancer-diagnostics-market